Results 21 to 30 of about 8,194 (217)

Stratifying Disease Progression in Patients With Cardiac ATTR Amyloidosis [PDF]

open access: yesJournal of the American College of Cardiology
Adam Ioannou, Rishi K Patel
exaly   +2 more sources

Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis

open access: yesNature Communications, 2021
ATTR amyloidosis causes heart failure through the accumulation of misfolded transthyretin in cardiac muscle. Here the authors report a mouse model of ATTR amyloidosis and demonstrate the involvement of protease activity in ATTR amyloid deposition.
Ivana Slamova   +18 more
doaj   +1 more source

Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner

open access: yesBMC Family Practice, 2020
Background Transthyretin amyloidosis (also known as ATTR amyloidosis) is a systemic, life-threatening disease characterized by transthyretin (TTR) fibril deposition in organs and tissue. A definitive diagnosis of ATTR amyloidosis is often a challenge, in
Morie Gertz   +23 more
doaj   +1 more source

Conjunctival lymphangiectasia and retinal angiopathy in hereditary transthyretin amyloidosis

open access: yesInternational Journal of Retina and Vitreous, 2022
Background Hereditary transthyretin amyloidosis (ATTR amyloidosis) is a rare condition where a mutation in the transthyretin gene leads to systemic deposition of amyloid.
Nikhil S. Patil   +2 more
doaj   +1 more source

Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining

open access: yesHuman Genomics, 2021
Background Familial transthyretin (TTR) amyloidosis (ATTR) is an autosomal dominant disease with significant phenotypic heterogeneity. Its prevalence in Saudi Arabia has not previously been investigated.
Mohamed Abouelhoda   +6 more
doaj   +1 more source

Uncovering the Mechanism of Aggregation of Human Transthyretin. [PDF]

open access: yes, 2015
The tetrameric thyroxine transport protein transthyretin (TTR) forms amyloid fibrils upon dissociation and monomer unfolding. The aggregation of transthyretin has been reported as the cause of the life-threatening transthyretin amyloidosis.
Cascio, Duilio   +9 more
core   +2 more sources

Best Practices in Specialized Amyloidosis Centers in the United States: A Survey of Cardiologists, Nurses, Patients, and Patient Advocates

open access: yesClinical Medicine Insights: Cardiology, 2021
Background: Because transthyretin amyloid cardiomyopathy (ATTR-CM) poses unique diagnostic and therapeutic challenges, referral of patients with known or suspected disease to specialized amyloidosis centers is recommended.
Jose Nativi-Nicolau   +7 more
doaj   +1 more source

The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa [PDF]

open access: yes, 2016
Transthyretin (TTR) pV142I (rs76992529-A) is one of the 113 variants in the human TTR gene associated with systemic amyloidosis. It results from a G to A transition at a CG dinucleotide in the codon for amino acid 122 of the mature protein (TTR V122I ...
Alexander, Alice A   +10 more
core   +1 more source

Electrophysiological demyelinating features in hereditary ATTR amyloidosis [PDF]

open access: yesAmyloid, 2019
To elucidate the electrophysiological demyelinating features in patients with hereditary ATTR amyloidosis that may lead to a misdiagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP).In 102 patients with hereditary ATTR amyloidosis (85 Val30Met and 17 non-Val30Met; 37 and 65 from endemic and non-endemic areas, respectively), results of ...
Nobuhiko, Ohashi   +3 more
openaire   +2 more sources

Antibody-Associated Reversal of ATTR Amyloidosis–Related Cardiomyopathy

open access: yesNew England Journal of Medicine, 2023
No ...
Marianna Fontana   +23 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy